What is DA Davidson’s Estimate for Clorox FY2025 Earnings?

The Clorox Company (NYSE:CLX) – Equities research analysts at DA Davidson issued their FY2025 EPS estimates for shares of Clorox in a research note issued to investors on Wednesday, February 5th. DA Davidson analyst L. Weiser forecasts that the company will earn $6.65 per share for the year. DA Davidson currently has a “Neutral” rating and a $169.00 target price on the stock. The consensus estimate for Clorox’s current full-year earnings is $6.86 per share. DA Davidson also issued estimates for Clorox’s FY2026 earnings at $6.32 EPS.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same period last year, the firm posted $2.16 earnings per share.

Other research analysts have also issued research reports about the company. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and boosted their price objective for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Evercore ISI increased their price objective on shares of Clorox from $145.00 to $155.00 in a report on Tuesday. JPMorgan Chase & Co. boosted their target price on shares of Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday. Finally, StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $158.21.

Clorox Stock Performance

Shares of CLX stock opened at $148.51 on Friday. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The business has a 50 day moving average of $161.44 and a two-hundred day moving average of $158.59. The company has a market cap of $18.38 billion, a P/E ratio of 51.75, a PEG ratio of 2.92 and a beta of 0.42. Clorox has a 52 week low of $127.60 and a 52 week high of $171.37.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.29%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s payout ratio is currently 170.04%.

Institutional Investors Weigh In On Clorox

Institutional investors and hedge funds have recently bought and sold shares of the business. Insight Folios Inc raised its holdings in shares of Clorox by 3.0% in the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after purchasing an additional 63 shares in the last quarter. Integral Investment Advisors Inc. grew its position in Clorox by 4.1% in the fourth quarter. Integral Investment Advisors Inc. now owns 1,718 shares of the company’s stock worth $279,000 after buying an additional 67 shares during the last quarter. HCR Wealth Advisors increased its holdings in shares of Clorox by 1.0% in the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock valued at $1,116,000 after buying an additional 68 shares in the last quarter. Sound View Wealth Advisors Group LLC lifted its position in shares of Clorox by 6.1% during the 4th quarter. Sound View Wealth Advisors Group LLC now owns 1,345 shares of the company’s stock valued at $218,000 after acquiring an additional 77 shares during the last quarter. Finally, Empower Advisory Group LLC boosted its stake in shares of Clorox by 4.5% during the 3rd quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock worth $297,000 after acquiring an additional 78 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.